Clinical Trial Update: Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of paclitaxel plus gemcitabine and cisplatin in urinary bladder neoplasms was terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Bladder Neoplasms

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Urinary Bladder Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2018-10-10